HS
Himani Shukla
About Himani Shukla
Data last updated:
Himani Shukla is a Director at Nucleus Laboratories (India) Limted (since 2025). The company operates in Pharma. Nucleus Laboratories (India) Limted reported revenue of ₹2.48 Cr (FY 2020).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Nucleus Laboratories (India) Limted U24231UP1999PLC024944 | Director | 01 Aug 2025 | 1999 | ₹2.48 Cr (FY 2020) | Active |
Board colleagues of Himani Shukla
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ashish Kumar Singh | 01189756 | Nucleus Laboratories (India) Limted | Director |
| Chandana Shrivastava | 09523772 | Nucleus Laboratories (India) Limted | Director |
| Debashish Saha | 10160104 | Nucleus Laboratories (India) Limted | Director |
| Gyan Prakash Shrivastava | 08545629 | Nucleus Laboratories (India) Limted | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Himani Shukla
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Himani Shukla
Himani Shukla currently holds 1 directorship: Nucleus Laboratories (India) Limted (Director, since 01 Aug 2025, revenue ₹2.48 Cr (FY 2020)).
Himani Shukla was first appointed on 01 Aug 2025 as Director at Nucleus Laboratories (India) Limted.
The current boards of Himani Shukla's companies include Ashish Kumar Singh (Nucleus Laboratories (India) Limted), Chandana Shrivastava (Nucleus Laboratories (India) Limted), Debashish Saha (Nucleus Laboratories (India) Limted), Gyan Prakash Shrivastava (Nucleus Laboratories (India) Limted).